Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Amgen .
Filed returns
5
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| May–Aug 2026 | Amgen | EU Affairs | Participation in a multi stakeholder life sciences roundtable on EU and Irish policy issues affecting the sector's competitiveness (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2025 | Amgen | Health | Discussion of Critical Medicines Act and other biopharma industry topics (Legislation) | 2 | On lobbying.ie |
| Sep–Dec 2024 | Amgen | Health | Discussed Amgen's current and future investments in Ireland; discussed EU Pharma Legislation. (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2024 | Amgen | Health | Discussed EU pharmaceutical legislation, market access to innovative medicines, and Amgen's manufacturing footprint in Ireland (Legislation) | 1 | On lobbying.ie |
| May–Aug 2024 | Amgen | Health | Request for meeting with Minister Burke regarding life sciences policy (Public policy or programme) | 2 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 4 | 80.0% | |
| EU Affairs | 1 | 20.0% |